…
Now live: Pro — the full 13F research suite for serious investorsSee pricing →
← Tracker

Institutional

Catalys Pacific, LLC

CIK 0002011385
$230.7M
Reported AUM
2
Positions
Q1 2026
Period
2026-05-14
Filed

The Brief · Catalys Pacific, LLC · Q1 2026

AI · grounded in 13F

Catalys Pacific, LLC increased its position in Phathom Pharmaceuticals, Inc. PHAT by 4.54%. The fund added one new position to its portfolio. Total assets under management stand at $230.71 million across two positions.

Portfolio · Q1 2026

MLYS$214.1MPHAT$16.6MCL

Top holdings

#StockIssuerPriceDay %1Y Gr.5Y Gr.Value% of bookΔ shares (QoQ)Status
1MLYSMineralys Therapeutics, Inc.$26.35-2.23%94.44%69.67%$214.1M92.81%—HELD
2PHATPhathom Pharmaceuticals, Inc.$11.64-0.17%39.64%-67.24%$16.6M7.19%—HELD

Source: SEC EDGAR · accession 0001104659-26-060911. 13F discloses long positions only — shorts, foreign equities, and options are excluded.